Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
1994-6-14
|
pubmed:abstractText |
Presentation of hen egg lysozyme (HEL) by HEL-specific B cells was studied in transgenic mice expressing anti-HEL immunoglobulin (Ig-transgenic). In T hybridoma assays, presentation of the HEL46-61 determinant by B cells from Ig-transgenic mice required 10(3)-10(4)-fold lower concentrations of HEL than were required for presentation by B cells from non-transgenic mice. In contrast, presentation of the HEL determinants 112-129 and 25-43 by HEL-specific B cells was either not significantly enhanced, or enhanced only 10-fold compared with B cells from non-transgenic mice. Enhanced presentation of HEL determinants by B cells from Ig-transgenic donors was specific for HEL, since keyhole limpet hemocyanin or synthetic HEL46-61 peptide were presented comparably by B cells from Ig-transgenic mice and non-transgenic littermates. A minimum of 1-4% Ig-transgenic B cells was required to detect enhanced presentation of HEL46-61 in vitro. Constitutive presentation of the HEL46-61 determinant, but not the HEL25-43 or HEL112-129 determinants, was detectable on anergic HEL-specific B cells from double (HEL/Ig)-transgenic mice. In the presence of exogenously added HEL, anergic B cells presented all three HEL determinants. Constitutively presented HEL46-61 was not due to endogenous synthesis of HEL antigen by anergic B cells from double-transgenic mice, as comparable levels of the HEL46-61 determinant were constitutively presented by B cells from Ig-Tg-->HEL-Tg irradiation bone marrow chimeric mice. Firstly, these results indicate that the enhanced antigen presentation mediated by Ig receptors on B cells is not equivalent for all antigenic determinants. Secondly, the data demonstrate that anergic, autoreactive B cells efficiently process and present nominal antigens in addition to constitutively presenting specific self antigen in vivo.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0014-2980
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
24
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1186-93
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:7514133-Animals,
pubmed-meshheading:7514133-Antigen-Presenting Cells,
pubmed-meshheading:7514133-B-Lymphocytes,
pubmed-meshheading:7514133-Bone Marrow Transplantation,
pubmed-meshheading:7514133-Clonal Anergy,
pubmed-meshheading:7514133-Egg Proteins,
pubmed-meshheading:7514133-Epitopes,
pubmed-meshheading:7514133-Lymphocyte Activation,
pubmed-meshheading:7514133-Mice,
pubmed-meshheading:7514133-Mice, Inbred C57BL,
pubmed-meshheading:7514133-Mice, Transgenic,
pubmed-meshheading:7514133-Muramidase,
pubmed-meshheading:7514133-Radiation Chimera,
pubmed-meshheading:7514133-Receptors, Fc,
pubmed-meshheading:7514133-Self Tolerance,
pubmed-meshheading:7514133-T-Lymphocytes
|
pubmed:year |
1994
|
pubmed:articleTitle |
Anergic B cells constitutively present self antigen: enhanced immunoglobulin receptor-mediated presentation of antigenic determinants by B cells is hierarchical.
|
pubmed:affiliation |
Centre for Transfusion Medicine and Immunology, Flinders Medical Centre, Bedford Park, Australia.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|